February 27, 2020

David A. Westrup

David Westrup is an equity shareholder and member of the firm’s Litigation and Risk Management Practice Group and Chair of the Drug and Medical Device Litigation Section. He advises insurers and corporations in minimizing product, environmental, and antitrust risks. He is panel counsel (Environmental, Life Sciences) for national insurance companies. He acts as special counsel on U.S. products and insurance law in overseas matters, including in matters before the House of Lords and the High Court of Australia. He is AV Preeminent rated with Martindale-Hubbell.

David cost-effectively manages risk and resolves disputes, using technology to improve outcomes and lower costs. He works extensively with claim management databases, some of which he has personally developed. He has represented corporations in numerous matters, either as national coordinating counsel, mediation/arbitration counsel, or as trial counsel in cases proceeding to verdict. 

Articles in the National Law Review database by David A. Westrup